Melola Discovery

← Melola Discovery

Journal SINTA 1

Correlation between HbA1c levels and intrastent restenosis incidence in patients with diabetes mellitus after percutaneous coronary intervention at Dr. Saiful Anwar General Hospital

Heart Science Journal · Vol. 5 No. 4 (2024) · pp. 60–64

DOI
10.21776/ub.hsj.2024.005.04.10
ISSN
2721-9984, 2721-9976
Published
2024-10-28
Publisher
Universitas Brawijaya
Language
en

Abstract

Background: Patients with chronic uncontrolled diabetes mellitus as indicated by HbA1c levels ≥ 6.5%, increase the risk of atherosclerosis, thereby increasing in-stent restenosis incidence during and after percutenous coronary intervention. Regular monitoring of HbA1c is crucial to reduce the incidence of in-stent restenosis.Objective: This study aims to ascertain the correlation between HbA1c levels and in-stent restenosis incidence in diabetes mellitus patients after percutenous coronary intervention at Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia.Methods/Design: Analytical observational study with a retrospective cohort study approach to determine the correlation between HbA1c levels and the incidence of in-stent restenosis in patients with diabetes mellitus after percutenous coronary intervention. The research sample was carried out by consecutive sampling in January 2021-December 2023.Results: This study has recruited 555 patients with coronary artery disease and diabetes mellitus. The average age of coronary heart disease patients with diabetes mellitus was 59 years. Patients with HbA1c levels ≥6.5 were more prone to experience in-stent restenosis 54 patients, while those with HbA1c levels <6.5 were more prone not to experience in-stent restenosis 388 patients, indicating a significant correlation between HbA1c and in-stent restenosis p=0.024. in-stent restenosis was most frequently observed in the LAD 44 patients, RCA 13 patients, LCx 10 patients, and LM 0 patient. The highest percentage of in-stent restenosis cases was over 70%, with 3VD lesions being the most common 55 patients. OAD therapy is most often given to coronary heart disease patients with diabetes mellitusConclusion: There is a correlation between HbA1c levels and the incidence of in-stent restenosis in diabetes mellitus patients after percutaneous coronary intervention, underscoring the necessity for routine blood glucose monitoring to prevent in-stent restenosis.

Keywords

Collaboration network of the authors

40 authors · 282 co-authorship links · 5 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • University of Brawijaya
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Setyasih AnjarwaniUniversity of Brawijaya33
Anna Fuji RahimahUniversity of Brawijaya28
Ardian RizalUniversity of Brawijaya27
Budi SatrijoUniversity of Brawijaya26
Cholid Tri TjahjonoUniversity of Brawijaya23
Novi KurnianingsihUniversity of Brawijaya19
Heny MartiniUniversity of Brawijaya17
Sasmojo WiditoUniversity of Brawijaya13
Djanggan SargowoUniversity of Brawijaya12
Yoga WaranugrahaUniversity of Brawijaya9
Wella KarolinaUniversity of Brawijaya8
Tri AstiawatiUniversity of Brawijaya5
Putri Annisa KamilaUniversity of Brawijaya5
Valerinna YogibuanaAffiliation unknown5
Adhika Prastya WikanandaUniversity of Brawijaya4
Tria Yudha NugrahaUniversity of Brawijaya4
Muhammad Rizki FadlanUniversity of Brawijaya4
Danti Utami SetyowatiRSUD Prof. Dr. Saiful Anwar Malang4
Seprian WidasmaraUniversity of Brawijaya4
Fahreza CaesarioUniversity of Brawijaya4
Dadang HendrawanUniversity of Brawijaya3
Fandy HazzyUniversity of Brawijaya3
Oktivani Adelathifa RahmaUniversity of Brawijaya3
Anna Fuji RahimahAffiliation unknown3
Ratna PancasariUniversity of Brawijaya3
Ayu Asri Devi AdityawatiUniversity of Brawijaya3
Lutfi Hafiz ZunardiUniversity of Brawijaya3
Mokhamad Aswin BaharUniversity of Brawijaya3
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya3
Veny KurniawatiUniversity of Brawijaya2
Tonny AdriyantoUniversity of Brawijaya2
Jonny Karunia FajarUniversity of Brawijaya2
Olivia HandayaniUniversity of Brawijaya2
Yoseph Budi UtomoUniversity of Brawijaya2
Ardian RizalUniversity of Brawijaya2
Taufieq Ridlo MakhmudUniversity of Brawijaya2
Faris Wahyu NugrohoUniversity of Brawijaya2

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, first harvested 8 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Correlation between HbA1c levels and intrastent restenosis incidence in patients with diabetes mellitus after percutaneous coronary intervention at Dr. Saiful Anwar General Hospital</dc:title>
	<dc:creator xml:lang="en">Millisani, Hayla Iqda</dc:creator>
	<dc:creator xml:lang="en">Prasetya, Indra</dc:creator>
	<dc:creator xml:lang="en">Rohman, Mohammad Saifur</dc:creator>
	<dc:subject xml:lang="en">HbA1c</dc:subject>
	<dc:subject xml:lang="en">Intrastent Restenosis</dc:subject>
	<dc:subject xml:lang="en">Diabetes Mellitus</dc:subject>
	<dc:subject xml:lang="en">Percutaneous Coronary Intervention.</dc:subject>
	<dc:description xml:lang="en">Background: Patients with chronic uncontrolled diabetes mellitus as indicated by HbA1c levels ≥ 6.5%, increase the risk of atherosclerosis, thereby increasing in-stent restenosis incidence during and after percutenous coronary intervention. Regular monitoring of HbA1c is crucial to reduce the incidence of in-stent restenosis.Objective: This study aims to ascertain the correlation between HbA1c levels and in-stent restenosis incidence in diabetes mellitus patients after percutenous coronary intervention at Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia.Methods/Design: Analytical observational study with a retrospective cohort study approach to determine the correlation between HbA1c levels and the incidence of in-stent restenosis in patients with diabetes mellitus after percutenous coronary intervention. The research sample was carried out by consecutive sampling in January 2021-December 2023.Results: This study has recruited 555 patients with coronary artery disease and diabetes mellitus. The average age of coronary heart disease patients with diabetes mellitus was 59 years. Patients with HbA1c levels ≥6.5 were more prone to experience in-stent restenosis 54 patients, while those with HbA1c levels &amp;lt;6.5 were more prone not to experience in-stent restenosis 388 patients, indicating a significant correlation between HbA1c and in-stent restenosis p=0.024. in-stent restenosis was most frequently observed in the LAD 44 patients, RCA 13 patients, LCx 10 patients, and LM 0 patient. The highest percentage of in-stent restenosis cases was over 70%, with 3VD lesions being the most common 55 patients. OAD therapy is most often given to coronary heart disease patients with diabetes mellitusConclusion: There is a correlation between HbA1c levels and the incidence of in-stent restenosis in diabetes mellitus patients after percutaneous coronary intervention, underscoring the necessity for routine blood glucose monitoring to prevent in-stent restenosis.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2024-10-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20127</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2024.005.04.10</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 5 No. 4 (2024): The Current Perspective About Cardiometabolic Disease; 60-64</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2024.005.04</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20127/458</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Hayla Iqda Millisani</dc:rights>
</oai_dc:dc>